Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.265 USD | +0.15% |
|
-9.05% | -12.70% |
Jun. 26 | Intellia Therapeutics Names Edward Dulac CFO | MT |
Jun. 26 | Intellia Therapeutics, Inc. Announces Chief Financial Officer Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.70% | 371M | |
+16.13% | 122B | |
+19.65% | 115B | |
+21.22% | 26.64B | |
-23.84% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.28% | 15.49B | |
+63.81% | 14.83B | |
+1.94% | 13.67B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Insider Sell: Fate Therapeutics